Table 2

Associations at time of inclusion between plasma soluble CD18 levels in all spondyloarthritis patients and self-assessment scores after correction for age, disease duration, HLA-B27 status, and treatment
BASDAI BASFI Patient pain Patient global Morning stiffness, level Morning stiffness, duration
sCD18 ra -0.29 -0.083 -0.14 -0.11 -0.27 -0.15
P 0.026 0.54 0.30 0.42 0.042 0.26

Bold numbers indicate significant correlations. aPartial correlation coefficients. BASDAI, Bath Ankylosing Spondylitis Disease Activity Index; BASFI, Bath Ankylosing Spondylitis Functional Index; sCD18, soluble CD18.

Kragstrup et al.

Kragstrup et al. Arthritis Research & Therapy 2014 16:R42   doi:10.1186/ar4471

Open Data